For Chronic Myelomonocytic Leukemia (CMML), there are several treatment options available, though not necessarily new. Here are some of the treatments mentioned:

- Chemotherapy: Drugs like Hydrea (hydroxyurea) or Cytosar-U (cytarabine) are used. Additionally, FDA-approved drugs for CMML include
- Vidaza (azacitidine)
Show Full Answer

For Chronic Myelomonocytic Leukemia (CMML), there are several treatment options available, though not necessarily new. Here are some of the treatments mentioned:

- Chemotherapy: Drugs like Hydrea (hydroxyurea) or Cytosar-U (cytarabine) are used. Additionally, FDA-approved drugs for CMML include:
- Vidaza (azacitidine)
- Dacogen (decitabine)
- Inqovi (decitabine and cedazuridine)

- Stem Cell Transplantation: This is an option for younger, healthier individuals with advanced leukemia, a matched donor, and leukemia not responding to other treatments. It carries serious risks.

- Supportive Care: This includes blood transfusions and platelet transfusions to manage symptoms and improve quality of life.

- Treatments for the Spleen: Radiation therapy or surgical removal of the spleen may be considered if the spleen is enlarged.

These treatments aim to manage symptoms and improve quality of life rather than cure CMML.

 This AI-generated response comes from MyLeukemiaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Chronic Myelomonocytic Leukemia: An Overview | MyLeukemiaTeam

Chronic Myeloid Leukemia Treatment Options | MyLeukemiaTeam